Author(s): Nizhevich AA, Iunusbaev BB, Tugunov MM, Tsiglintseva NP, Nasretdinova EK
Abstract Share this page
Abstract THE AIM of this study was to determine the effects of CYP2C19 polymorphism on H. pylori eradication in pediatric population in the Republic of Bashkortostan. METHODS: Fifty-nine children were entered into the study (age range: 12 to 17; 22 female). All the patients were infected with H. pylori and received the combination of omeprazole (1 mg/kg/day), furazolidone (10 mg/kg/day) and amoxicilline (25 mg/kg/day) or clarithromycin (7.5 mg/kg/day) for 10 days. The participants were classified into 3 groups according to CYP2C19 genotype; rapid metabolizers (RM) (54.2\%), intermediate metabolizers (IM) (35.6\%) and poor metabolizers (PM) (10.2\%). H. pylori infection status was assessed before and after the treatment. RESULTS: The eradication rate was 65.6\% for RM, 71.4\% for IM, and 83.3\% for PM. CONCLUSION: The present study confirmed the low eradication rate for RM and for the IM groups. Alternative regimens expected to be with a higher eradication rate should be recommended (rabeprazole-based treatment).
This article was published in Eksp Klin Gastroenterol
and referenced in Journal of Pharmacogenomics & Pharmacoproteomics